GSK receives US breakthrough therapy designation for lung cancer treatment pharma Pharmaceutical group GSK has been granted breakthrough therapy designation by the US Food and Drug Administration (FDA) for a key lung cancer treatment. The breakthrough therapy designation is designed to expedite the development and review of drugs with the potential to treat a serious condition. Only treatments that are shown to offer a substantial improvement [...]
GSK: Pharma giant raises guidance after second quarter sales give shot in the arm Business London-listed pharma giant GSK has raised its guidance after a strong second quarter beat market expectations, boosted by its cancer and HIV portfolio. Total sales in the second quarter of 2024 reached £7.9bn, an increase of 13 per cent year on year. Core operating profit at the pharma company rose by 18 per cent on [...]
GSK moves into New Oxford Street office in boost for central London Pharma GSK has opened the doors to its new West End office - called the Earnshaw.
FTSE 100 pharma giant GSK kicks off Zantac appeal as company seeks to limit damages June 11, 2024 GSK has launched an appeal against the Delaware Superior Court's recent so-called Daubert ruling.
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial ruling June 3, 2024 GSK has hit back against a US ruling that found it could be sued over the potential cancer-causing properties of its heartburn drug Zantac.